(Q42463552)

PubMed publication ID

25100593

1 November 2017

title

Reduction of brain kynurenic acid improves cognitive function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

18

Stacy A Castner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

author name string

Rouba Kozak

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Brian M Campbell

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Christine A Strick

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Weldon Horner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

William E Hoffmann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Tamas Kiss

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Douglas S Chapin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Dina McGinnis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Amanda L Abbott

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Brooke M Roberts

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Kari Fonseca

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Victor Guanowsky

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Damon A Young

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Patricia A Seymour

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Amy Dounay

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Mihaly Hajos

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

Graham V Williams

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

language of work or name

English

0 references

publication date

1 August 2014

1 reference

PubMed publication ID

25100593

1 November 2017

published in

Journal of Neuroscience

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

issue

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

page(s)

10592-10602

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus

12 May 2020

cites work

1 reference

12 December 2020

Role of Thalamic Projection in NMDA Receptor-Induced Disruption of Cortical Slow Oscillation and Short-Term Plasticity

1 reference

12 December 2020

Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum

1 reference

12 December 2020

Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia.

1 reference

12 December 2020

Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys.

1 reference

12 December 2020

1 reference

12 December 2020

Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia

1 reference

12 December 2020

Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia

1 reference

12 December 2020

Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery

1 reference

12 December 2020

Increased cortical kynurenate content in schizophrenia

1 reference

12 December 2020

Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry

1 reference

12 December 2020

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

1 reference

12 December 2020

N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives

1 reference

12 December 2020

Amelioration of ketamine-induced working memory deficits by dopamine D1 receptor agonists

1 reference

12 December 2020

Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats.

1 reference

12 December 2020

Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid

1 reference

12 December 2020

[3H]MDL 105,519, a high-affinity radioligand for the N-methyl-D-aspartate receptor-associated glycine recognition site.

1 reference

12 December 2020

Neurophysiological biomarkers for drug development in schizophrenia

1 reference

12 December 2020

Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.

1 reference

12 December 2020

Working memory dysfunction in schizophrenia

1 reference

12 December 2020

L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning.

1 reference

12 December 2020

Micromolar Brain Levels of Kynurenic Acid are Associated with a Disruption of Auditory Sensory Gating in the Rat

1 reference

12 December 2020

Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum.

1 reference

12 December 2020

Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior

1 reference

12 December 2020

Electrophysiological characterisation of the actions of kynurenic acid at ligand-gated ion channels

1 reference

12 December 2020

Elevations of endogenous kynurenic acid produce spatial working memory deficits

1 reference

12 December 2020

The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex

1 reference

12 December 2020

Discovery of Brain-Penetrant, Irreversible Kynurenine Aminotransferase II Inhibitors for Schizophrenia.

1 reference

12 December 2020

Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood

1 reference

12 December 2020

N-methyl-D-aspartate receptor-coupled glycineB receptors in the pathogenesis and treatment of schizophrenia: a critical review

1 reference

12 December 2020

Nicotine-dizocilpine interactions and working and reference memory performance of rats in the radial-arm maze

1 reference

12 December 2020

Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density

1 reference

12 December 2020

A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats

1 reference

12 December 2020

Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia.

1 reference

12 December 2020

Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain.

1 reference

12 December 2020

Immediate and sustained improvements in working memory after selective stimulation of α7 nicotinic acetylcholine receptors.

1 reference

12 December 2020

Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery.

1 reference

12 December 2020

Enhanced control of attention by stimulating mesolimbic-corticopetal cholinergic circuitry.

1 reference

12 December 2020

Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at alpha7* nicotinic receptors.

1 reference

12 December 2020

Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia

1 reference

12 December 2020

10.1523/JNEUROSCI.1107-14.2014

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6802596&resulttype=core&format=json

12 May 2020

PubMed publication ID

25100593

1 reference